NCT01155141View on ClinicalTrials.gov

Idiopathic Focal Segmental Glomerulosclerosis (FSGS) and Treatment With ACTH

PHASE4CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
Kidney Diseases
Interventions
DRUG

H.P. Acthar Gel

Patients were treated with 40 units subcutaneously (SC) weekly for 2 weeks, then dose increased to 80 units SC weekly for 2 weeks followed by 80 units SC twice weekly to complete 16 weeks of therapy.

Trial Locations (1)

94305

Stanford University School of Medicine, Stanford

Sponsors

Collaborators (1)

Mallinckrodt
All Listed Sponsors
collaborator

Mallinckrodt

INDUSTRY

lead

Stanford University

OTHER